JPRN-UMIN000028006招募中未知
We conduct intense LDL-C lowering therapy for patients with asymptomatic cervical internal carotid stenosis and evaluate signal change of carotid plaque on MRI-VISTA - Study of intense lipid-lowering effect on carotid MRI signal change
Hyogo Brain and Heart Center at Himeji0 个研究点目标入组 10 人开始时间: 2017年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet any of the following exclusion criteria 1. Patients with symptomatic cervical internal carotid artery stenosis 2. Patients with serious renal impairment 3. Patients with hepatic dysfunction 4. MRI incompatible patients
研究者
相似试验
已完成
不适用
Aggressive lipid-lowering treatment approaches for vulnerable plaque in coronary artery with rosuvastatin. -Assessment using angioscopy and intravascular ultrasoundHypercholesterolemiaJPRN-UMIN000003276ALTAIR Study50
已完成
不适用
Effect of Intensive LDL-C Lowering with High-dose Atorvastatin on Inflammation and Postoperative Organ Damage in Patients Undergone Coronary Artery Bypass Surgerycoronary artery diseaseJPRN-UMIN000006879Juntendo University Hospital90
已完成
4 期
Randomized trial of Lipid lowering Therapy for Endothelial Function;Statin Monotherapy Compared with Statin/Ezetimibe or Statin/Eicosapentaenoic Acid Combination TherapyJPRN-UMIN000008060Fukuoka wajiro hospital80
已完成
不适用
Intensive LOwering of BlOod low-density lipoprotein ChOlesterol with statin + ezetimibe therapy improves cardiac function after Percutaneous coronary intervention in patients with coronary stenting in Fukuoka-II (LOBOCOP-II)Ischemic heart diseaseJPRN-UMIN000001782Heart/vascular internal medicine,fukuoka university200
已完成
3 期
Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)HypercholesterolemiaNCT02107898Sanofi216